Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis
Binbin Chen, Huimou Chen, Suying Lü, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 23

Showing 23 citing articles:

AURKA inhibition induces Ewing’s sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis
Huimou Chen, Jing Hu, Xilin Xiong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation
Yaqing Zhou, Jiaxin Jiang, Shuai He, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 13
Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis
Jiaojuan Huang, Shuiling Jin, Rongqun Guo, et al.
RNA (2024) Vol. 30, Iss. 4, pp. 435-447
Closed Access | Times Cited: 4
Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
Yasuyo Ohguchi, Hiroto Ohguchi
Cancers (2022) Vol. 14, Iss. 13, pp. 3270-3270
Open Access | Times Cited: 17
STYX Interacts with FBXW7 to Promote AML Proliferation via Inhibiting the Ubiquitination of CCNE1
Rui Yang, Jing Ning, Hainan Wang, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Identifying KDM5B as the synthetic lethal target of KMT2D-mutated osteosarcoma
Liyu Yang, Jing Zhang, Yiting Jiang, et al.
Chemico-Biological Interactions (2025) Vol. 412, pp. 111451-111451
Closed Access
Ubiquitination in lipid metabolism reprogramming: implications for pediatric solid tumors
Weixin Zhang, Yile Xu, Yapeng Fang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tumour cell-derived serglycin promotes IL-8 secretion of CAFs in gastric cancer
Xiang Li, Guiping Xie, Jia Chen, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 271-282
Open Access | Times Cited: 3
Downregulation of BASP1 promotes temozolomide resistance in gliomas via epigenetic activation of the FBXO32/NF-κB/MGMT axis
Xinyi Liao, Ziwen Li, Haiqing Zheng, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 7, pp. 648-663
Open Access | Times Cited: 6
The Targeted Therapies for Osteosarcoma via Six Major Pathways
Shuxing Wang, Quanlei Ren, Guoqing Li, et al.
Current Molecular Pharmacology (2023) Vol. 17
Open Access | Times Cited: 6
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
L. Xing, Leidi Xu, Yong Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma
Quincy C. C. van den Bosch, Josephine Q.N. Nguyen, Tom Brands, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3668-3668
Open Access | Times Cited: 8
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
Zsuzsanna Gaál
Biomolecules (2022) Vol. 13, Iss. 1, pp. 61-61
Open Access | Times Cited: 8
SETD8 inhibits apoptosis and ferroptosis of Ewing’s sarcoma through YBX1/RAC3 axis
Huimou Chen, Jing Hu, Xilin Xiong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 1
SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesis
Mengzhen Li, Feifei Sun, Juan Wang, et al.
Oncogene (2024) Vol. 43, Iss. 45, pp. 3306-3320
Open Access | Times Cited: 1
KDM5B predicts temozolomide-resistant subclones in glioblastoma
Vivien Ullrich, Sarah Ertmer, Anna Baginska, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108596-108596
Open Access | Times Cited: 2
Co‐targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis
LaKendria K. Brown, Thanigaivelan Kanagasabai, Guoliang Li, et al.
The Prostate (2024) Vol. 84, Iss. 9, pp. 877-887
Closed Access
Unlocking epigenetics for precision treatment of Ewing's sarcoma.
Zhehao Fan, Shuangshuang Dong, Ning Wang, et al.
PubMed (2024) Vol. 36, Iss. 3, pp. 322-340
Closed Access
Effect of histone demethylase KDM5B on long-term cognitive impairment in neonatal rats induced by sevoflurane
Yanhong Wang, Yun Chen, Mengxiao Zhang, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Endothelial KDM5B Regulated by Piezo1 Contributes to Disturbed Flow Induced Atherosclerotic Plaque Formation
Lili Wu, Shanshan Jiang, Xiao Zhou, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 23
Closed Access
Genetic analyses identify evidence for a causal relationship between Ewing sarcoma and hernias
Tianzhong Yang, Lauren J. Mills, Aubrey K. Hubbard, et al.
Human Genetics and Genomics Advances (2023) Vol. 5, Iss. 1, pp. 100254-100254
Open Access
KDM5B as a potential epigenetic regulator of cardiomyocyte regeneration and cell cycle activation.
Dana Hammouri
(2023)
Open Access
Page 1

Scroll to top